The 20 Best Non-Small Cell Lung Cancer (NSCLC) Doctors Near Me in Ann Arbor, MI

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology.

Nithya Ramnath is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Ramnath is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Pleuropulmonary Blastoma.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Dr. De Cardenas is the Director of the Interventional Pulmonology Program at the University of Michigan and a Clinical Associate Professor of Medicine and Surgery. He is part of the multidisciplinary team at the University of Michigan that treats patients with complex airway and pleural diseases. He has specific expertise in minimally invasive advanced diagnostic and therapeutic bronchoscopic and pleural procedures, critical care ultrasonography and medical education. His academic interests include endobronchial device development for treatment of early lung cancer, pleural infectious diseases, and developing novel methods to teach procedural skills.Honors and Awards:2017 Nominee Emerging Educator Award - Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD)2014 Fellow of the Year, Department of Medicine. Zucker School of Medicine at Hofstra Northwell, NY2012 Best Teaching Senior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2011 Best Teaching Junior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2010 Best Teaching Intern, Leo M. Davidoff Society Awards, Albert Einstein College of MedicineCredentials:Medical SchoolMD, Facultad de Medicina. Universidad Nacional de Trujillo, Peru 2006ResidencyAlbert Einstein College of Medicine, Jacobi Medical Center, Internal Medicine, NY 2012FellowshipsHarvard Medical School, Combined Interventional Pulmonology Fellowship. Beth Israel Deaconess Medical and Massachusetts General Hospital, Boston, MA, 2016Zucker School of Medicine. Pulmonary and Critical Care Medicine, North Shore University Hospital and Long Island Jewish Medical Center, NY 2015Board Certifications2012: Board Certification in Internal Medicine2014: Board Certification in Pulmonary Medicine2016: Board Certification in Critical Care Medicine2017: Board Certification in Interventional Pulmonology. AABIP. Dr. De Cardenas is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Advanced Bronchoscopy, and Endoscopy. Dr. De Cardenas is board certified in Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonology.

Dr. Hyzy is the Medical Director of the Critical Care Medicine Unit and Co-Chair of the Critical Care Committee at the University of Michigan Hospital. Dr. Hyzy is a graduate of Kenyon College and NYU School of Medicine and trained in Internal Medicine and Pulmonary and Critical Care Medicine at the University of Michigan. Dr. Hyzy’s research interest in thin the intensive care unit including patients with the Acute Respiratory Distress Syndrome, sepsis and respiratory failure. In the Pulmonary Clinic he participated as a Co-Investigator in clinical trials in patients with Idiopathic Pulmonary Fibrosis and COPD. Dr. Hyzy is an active clinician and researcher with multiple publications including serving as editor of a critical care textbook published by Springer and 14 topics to the online medical reference UpToDate. Dr. Hyzy is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.

Max Wayne is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Wayne is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Pulmonary Alveolar Proteinosis, Lymphofollicular Hyperplasia, Endoscopy, and Pancreaticoduodenectomy.

Thomas Regenbogen is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Regenbogen is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

David Odell is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Odell is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy.

Rishindra M. Reddy, M.D., is the José José Alvarez Research Professor in Thoracic Surgery. He was born and raised in Michigan. He earned his undergraduate and medical degrees at Northwestern University, and completed his general surgery residency at Washington University-Barnes Jewish Hospital in St. Louis, Missouri. His spent two years during his residency, as a Clinical Research Fellow at the National Cancer Institute in Bethesda, Maryland. He completed his Thoracic Surgery residency at the University of Washington and was a visiting fellow at Memorial Sloan Kettering Cancer Center in New York. His academic interests include improving outcomes for patients with thoracic cancers, molecular targeting for thoracic cancers, resident and medical student education.Clinical Specialization: Dr. Reddy's clinical interests include all aspects of general thoracic surgery including thoracic oncology, minimally invasive techniques and robotics surgery, esophageal diseases, pectus repairs and therapy for end stage lung disease including transplantation and lung volume surgery. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Hiatal Hernia, Esophageal Cancer, Endoscopy, and Lung Transplant. Dr. Reddy is board certified in Surgery and Thoracic & Cardiac Surgery.

Andrew C. Chang, M.D., is the Cameron Haight Collegiate Professor of Thoracic Surgery at the University of Michigan. After completing his undergraduate education at the Massachusetts Institute of Technology and medical education at The Johns Hopkins University he pursued general surgical residency at Vanderbilt University. During this time he also obtained an individual National Research Service Award from the National Institutes of Health to study cardiothoracic transplantation with Richard N. Pierson, III, M.D. He then continued as a thoracic surgical resident and subsequently thoracic surgical fellow at the University of Michigan, completing these in 2003, before joining the faculty. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Achalasia, Hiatal Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Chang is board certified in Surgery and Thoracic & Cardiac Surgery.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Lawrence is board certified in Radiation Oncology, Medical Oncology, and Internal Medicine.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Dr. David Smith is a Professor of Internal Medicine and Urology at the University of Michigan and currently serves as the Associate Chief Clinical Officer for Cancer at Michigan Medicine and the Chief Medical Officer of the Rogel Cancer Center. Throughout his career he has focused on caring for patients with urologic cancers, cancer clinical trials, and the delivery of cancer care. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Orchiectomy, and Prostatectomy.

Chigozirim Ekeke is a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Ekeke is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pleural Effusion, Metastatic Pleural Tumor, Hiatal Hernia, Endoscopy, and Advanced Bronchoscopy.

Zachary Wilseck is a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Wilseck is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Arteriovenous Malformation, Stroke, Thrombectomy, and Stent Placement.

Dr. William M. Sherk is a board-certified Vascular Interventional Radiologist specializing in venous, lymphatic, and aortic diseases. He is co-lead of the steering committee of the Frankel Cardiovascular Center Venous Health Program, a multidisciplinary team focusing on the care of patients with complex venous problems. Dr. Sherk completed training at the University of Michigan in Interventional Radiology, where he served as Chief Resident. After residency, he joined the faculty at University of Michigan in the division of Interventional Radiology. His research focuses on the diagnosis and multidisciplinary treatments of venous disease, including chronic venous occlusion, cancer-related venous obstruction, and pulmonary embolism. He currently serves as the Program Director for the Integrated Interventional Radiology residency. Dr. Sherk is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Retroperitoneal Fibrosis, Intussusception in Children, May Thurner Syndrome, SVC Obstruction, and Thrombectomy. Dr. Sherk is board certified in Interventional Radiology & Diagnostic Radiology.

Hakan Oral is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Oral is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Cardiac Tamponade, Atrial Fibrillation, Ectopic Heartbeat, Cardiac Ablation, and Pacemaker Implantation. Dr. Oral is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

Dr. Derek Bergsma is active in clinical practice at the Lacks Cancer Center Department of Radiation Oncology in Grand Rapids. He received his undergraduate degree from Grand Valley State University and then worked in cancer immunodiagnostics at Van Andel Institute before obtaining his medical degree from Michigan State University College of Human Medicine. He completed both internship and Radiation Oncology residency at the University of Rochester in Rochester, NY. Dr. Bergsma is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Brain Tumor, Astrocytoma, and Oligodendroglioma. Dr. Bergsma is board certified in Radiation Oncology.